John C.K. Milligan, IV

2015

In 2015, John C.K. Milligan, IV earned a total compensation of $3.1M as President and Secretary at TherapeuticsMD, a 467% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$367,500
Option Awards$2,402,764
Salary$350,000
Other$20,404
Total$3,140,668

Milligan received $2.4M in option awards, accounting for 77% of the total pay in 2015.

Milligan also received $367.5K in non-equity incentive plan, $350K in salary and $20.4K in other compensation.

Rankings

In 2015, John C.K. Milligan, IV's compensation ranked 3,007th out of 13,638 executives tracked by ExecPay. In other words, Milligan earned more than 78.0% of executives.

ClassificationRankingPercentile
All
3,007
out of 13,638
78th
Division
Manufacturing
1,066
out of 5,190
80th
Major group
Chemicals And Allied Products
393
out of 1,854
79th
Industry group
Drugs
308
out of 1,528
80th
Industry
Pharmaceutical Preparations
244
out of 1,182
79th
Source: SEC filing on April 25, 2017.

Milligan's colleagues

We found four more compensation records of executives who worked with John C.K. Milligan, IV at TherapeuticsMD in 2015.

2015

Robert Finizio

TherapeuticsMD

Chief Executive Officer

2015

Daniel Cartwright

TherapeuticsMD

Chief Financial Officer

2015

Mitchell Krassan

TherapeuticsMD

Executive Vice President and Chief Strategy Officer

2015

Michael Donegan

TherapeuticsMD

Vice President - Finance

News

In-depth

You may also like